GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
FDA Approves Sanofi and Sobi’s Once-Weekly Hemophilia A Med
2023-02-23
CSL’s Hemgenix Wins First Gene Therapy Approval For Hemophilia In Europe
2023-02-21
Travere Snags Accelerated Approval for First Non-Immunosuppressive IgAN Therapy
2023-02-19
Apellis’ Syfovre Nets First FDA Approval For Geographic Atrophy
2023-02-18
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
ViiV Healthcare to Present First Head-to-head Data for New HIV Treatment Regimen Cabenuva Against Biktarvy
2023-02-15
FDA Slaps Refusal to File Letter on Soligenix’s Photodynamic Cancer Therapy Application
2023-02-14
Biocon and Viatris Hit Another FDA Wall with Avastin Biosimilar
2023-02-13
Roche’s Vision Loss Drug Clocks Two Phase 3 Wins In Macular Edema
2023-02-13
Immusoft’s B Cell Gene Therapy Gets FDA Nod to Enter Clinical Trials
2023-02-13
South Korea Puts Everest Medicines’ Nefecon On Fast Track
2023-02-10
AstraZeneca’s Forxiga Gets EU Nod To Treat Symptomatic Chronic Heart Failure
2023-02-08
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
1 2 3 4 46
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top